Monday’s analyst upgrades and downgrades
Inside the Market’s roundup of some of today’s key analyst actions
“Predictable growth is back” for Stantec Inc. (STN-T), according to National Bank Financial analyst Maxim Sytchev, seeing the Edmonton-based firm now “performing across all geographies and end markets” and striking a “confident tone” heading into 2027.
“We were hoping for U.S. re-acceleration, and we got it; importantly, it appears to be sustainable without the pull forward effect, although the U.S. administration changes could theoretically lead to some shifts in the short term,” said Mr. Sytchev. “The claims question was asked and management reaffirmed its view around coverage sufficiency.
“Looking forward, we believe 2027Eis setting up well given good backlog growth across the entire platform at the moment, supporting our organic growth projections (in the 5-per-cent range). When layering on margin expansion in the 40 basis points range, some NCIB, the EPS algorithm is producing growth of 9 per cent to 10 per cent. For a steady grower, a 15.6 times 2027 estimated P/E is reasonable in our view.”
On Friday, Stantec shares soared 13.8 per cent after it reported a 10-per-cent year-over-year revenue gain to $1.865-billion, exceeding both Mr. Sytchev’s $1.848-billion estimate and the consensus of $1.831-billion. Adjusted earnings per share of $1.89 also topped expectations ($1.77 and $1.78, respectively) as margins improved and its consolidated backlog jumped, which the analyst says “cements visibility.”
“STN achieved organic growth across every region this quarter, with the Water business leading the growth by expanding double digits organically,” he said. “Backlog grew +9.9 per cent on an organic basis and represents 13 months of work for STN at $9.2-billiom, with both Canada and Global delivering double-digit backlog growth in Q3/26. On a regional level, management expects the organic growth trends in Canada and the U.S. to continue into Q4/26E, supported by backlog expansion across end markets and healthy customer demand. STN remains confident in the U.S. market as it has the backlog in place – the challenge was accessibility to funding and some of that has now opened up, led by Water and Power & Energy. STN will also continue benefiting from IIJA for the next couple of years (as funds have been obligated while transportation has consistently been a bipartisan issue; recall, of course, that on a relative basis, STN has less transit exposure vs. some of its peers). Overall, delays in funding in the U.S. didn’t cause project cancellations but pushed the timing to the right. In Canada, the growth is broad-based, led by Water and supported by Oil & Gas in Western Canada; management is positive on Canada in the medium- to long-term, given the 167 major projects in the nation’s pipeline, although management acknowledges it will take some time for those projects to come online. Globally, Water and Energy & Resources grew double digits this quarter on strong activity in the UK (AMP 8) and LatAm mining. Management also noted recovery in Australia, which is (modestly) growing q/q now, and New Zealand.”
After modest adjustments to his forecast, Mr. Sytchev raised his target for Stantec shares to $122 from $120, keeping an “outperform” rating. The average target on the Street is $137.91.
“Management’s updated full-year guidance leaves our Q4/26E largely unchanged – not a bad thing given that our expectations re-accelerating growth and margin upside had materialized,” he explained. “For next year, we model 5-per-cent organic NR growth along with 40 basis points of incremental margin expansion on a mix of improved project margins and reduced SG&A intensity given the strong cost-control track record and focus on productivity improvements. That said, we do not pencil in unannounced M&A or additional share buybacks – both areas where we believe capital can be used accretively – leaving a degree of conservatism for our forecasts through 2027E.”
Elsewhere, others making target revisions include:
* RBC’s Sabahat Khan to $154 from $146 with an “outperform” rating.
“Stantec reported Q3 results ahead of expectations with good organic growth across its regions. Management commentary on the call indicated accelerating momentum in Q4, which also positions the company well heading into 2027. Year-over-year margin improvement was notable, with better- than-expected Adj. EBITDA margin in Q3, and full-year guidance revised above the high end of the prior range. All in, a good setup heading into next year, with visibility to the medium-term expected at the upcoming Investor Day,” said Mr. Khan.
* Desjardins Securities’ Benoit Poirier to $165 from $169 with a “buy” rating.
“The call supports our view that U.S. weakness in 1H was about timing. Canada looks like another key growth vector, with backlog up 18 per cent year-over-year organically and line of sight on many of the 150+ Investment Summit projects. Focus now turns to the investor day on December 8, where STN will present its next three-year strategic plan,” said Mr. Poirier.
* TD Cowen’s Michael Tupholme to $140 from $132 with a “buy” rating.
“We remain constructive on STN after Q3/26’s beat and management’s increased 2026 margin guidance. U.S. organic growth accelerated to 4.9 per cent year-over-year (vs. flat in Q2/26), as delayed backlog began to unlock. Ex-recoveries (50 basis points of project margin), EBITDA margin still expanded 70 basis points year-over-year on utilization/A&M leverage, and pricing remains balanced. We continue to like STN’s revenue growth & margin improvement potential,” said Mr. Tupholme.
* Scotia’s Jonathan Goldman to $130 from $124 with a “sector outperform” rating.
“STN shares are up 14 per cent intraday, well beyond the quantum of the beat of 6.4 per cent (closer to 3.6 per cent excluding outsized project recoveries) and our estimate revisions (2026E/2027E up 1.6 per cent/up 1 per cent), consistent with the re-rating trend we’re seeing across E&Cs,” said Mr. Goldman. “The consolidated peer group is now trading at 11.5 times EV/EBITDA on 2027 estimates vs. 11 times only two weeks ago. Judging by the nature of inbounds we have received and recent earnings call fodder, it seems that AI fears have dissipated to some degree and conversations have pivoted back to U.S. growth inflection and trend. Notably, the company held the guide for mid-single-digit organic growth in the U.S., which implies an even steeper reacceleration in 4Q. For context, we assume 4 per cent in 2026, which implies 8 per cent in 4Q – 5 per cent in 2026, implies 12 per cent in 4Q – and so on. Earnings call commentary was equally encouraging with management saying ‘we’re actually starting to see things like pick up again’ and ‘accessibility to funding has also started to hit key projects, and we see this continuing to accelerate.’ A lot of attention is paid to the U.S., but Canada should accelerate (organic backlog up 18 per cent year-over-year) while Global continues to be robust.”
Scotia Capital analyst Jonathan Goldman thinks CCL Industries Inc. (CCL.B-T) “represents a really good option for investors looking for ‘STARP’, or ‘staples at a reasonable price’ and called it “one of the most defensive names” in his coverage universe.
“Shares are trading at 10.5 times EV/EBITDA and 18.4 times P/E on our 2027 estimate, consistent with the company’s 10-year averages, but we believe they deserve a premium given: 1) defensive characteristics in a challenging macro environment; and 2) an observed inflection in capital allocation approach,” he explained. “The company repurchased 6.8 million shares year-to-date (4 per cent of shares outstanding), inclusive of repurchases subsequent to quarter-end for $610 million, more than the prior 10 years combined. Following the earnings call, we are more positive on the M&A outlook. We estimate announced M&A is on track to contribute 2.5-per-cent top-line growth in 2026 compared to 0.7 per cent last year.”
The Toronto-based specialty packaging and label manufacturer reported third-quarter revenue and adjusted EBITDA of $2.22-billion and $462-million, both exceeding the Street’s expectations of $2.11-billion and $443-million. The earnings beat was attributed to higher sales including organic growth of 6.9 per cent (versus the consensus projection of 4 per cent).
With the results, Mr. Goldman maintained his full-year forecast while increasing his 2027 expectations by 1 per cent.
“The nominal estimate changes are more a function of size (i.e., harder to move the needle) than underlying operating trends, which remain positive,” he said. “Further, what would have been more fulsome upward revisions are mitigated by lower margin assumptions in CCL Segment due to headwinds in CCL Design, which should be transitory. Consumer electronics companies are being impacted by memory chip shortages (autos and PCs); however, management emphasized this was really just a supply issue and not related to end-market demand. The rest of the business continues to perform well/have a positive outlook (i.e., HPC, F&B, healthcare stable, Checkpoint (ALS) easy comps, Innovia similar demand trends as 3Q)”
Maintaining his “sector perform” rating for CCL shares, he hiked his target to $109 from $98. The average is $113.78.
“It combines a GDP+ growth profile with stable margins and a strong track record of accretive M&A. With organic growth expected to reaccelerate, structural margin expansion opportunities, and conditions primed for large-scale M&A (and significant balance sheet flexibility), we see ample catalysts for the shares to break out of their six-year trading range,” he concluded.
Canaccord Genuity’s Amr Ezzat thinks the 12.5-per-cent selloff in shares of Vitalhub Corp. (VHI-T) on Friday in response to its quarterly release was “overdone” and believes its “problem is not broad-based.”
The Toronto-based healthcare software company reported quarterly revenue of $31.9-million, a fall of 0.4 per cent year-over-year and under both Mr. Ezzat’s $33.2-million estimate and the Street’s projection of $33.3-million. Adjusted EBITDA of $8.6-million also fell short of the analyst’s expectation of $8.3-million while narrowly topping the consensus of $8.7-million.
“SHREWD, the troubled UK platform currently dragging organic growth, represents roughly 7-8 per cent of VHI’s $107-million ARR [annual recurring revenue] base, or about $8-million,” he explained. What is a declining software asset with poor near-term visibility worth? 2 times ARR? 3 times? 4 times? Pick your number. That gets you to roughly $15-30-million, a fraction of the value wiped from the stock [Friday].
“So what explains the rest? We think the market is asking a broader question: is SHREWD the problem, or is SHREWD exposing a wider deterioration in VitalHub’s organic growth engine? Our work and due diligence continue to point to the former. The call reinforced that view. Management characterized the other 90%+ of the portfolio as performing strongly and suggested VHI would effectively be operating at Rule of 40 levels absent the SHREWD drag. Novari continues to grow, Strata’s pipeline is building, Zesty is outperforming expectations, Ontario continues to roll out, and services backlog is at a record. We simply do not see evidence of a portfolio-wide demand problem.”
Despite the miss, Mr. Ezzat feels SHREWD is “becoming easier to frame, even if the outcome remains messy.”
“Management sized the platform at roughly 7-8 per cent of ARR and emphasized that the business is not disappearing,” he explained. “Some customers continue to renew for multiple years, usage remains high, and others are moving between suspension, renewal, and non-renewal as NHS funding decisions evolve. The next meaningful marker is approaching: the Palantir arrangement includes a February 2027 break clause, which should force greater clarity over the coming months. In our view, the important point is less whether SHREWD ultimately settles at $6-million, $7-million, or $8-million of ARR and more that the problem appears increasingly contained to a relatively small part of the portfolio.
“There is plenty of growth underneath the headline number. Management expects Novari to grow to well above $20-million of ARR, while Strata has another $3-5-million of identified pipeline over the next couple of years and is seeing renewed activity in the U.S.. Zesty has exceeded management’s expectations since acquisition, Ontario continues to expand into additional pathways, and professional-services backlog is at a record with more milestones expected to convert in Q4. VitalHub is also increasingly integrating these products into a single platform, which management believes should support larger transactions and deeper cross-sell over time. None of this fixes today’s 8-per-cent organic growth print, but it gives us confidence that there is enough underlying momentum to drive a reacceleration once the SHREWD drag begins to normalize.”
Keeping his “buy” rating, Mr. Ezzat lowered his target to $14.50 from $15, which is the current average on the Street.
“Does that mean the stock rebounds meaningfully tomorrow? Probably not,” he said. “The catalyst is organic ARR growth. Investors need to see growth stop decelerating and begin moving higher before confidence returns, and we suspect that remains one or two quarters away. We have nevertheless refined our forecasts to reflect the softer near-term trajectory and trim our target to $14.50 (from $15.00). Against a ... decline in the shares [Friday], we think the distinction is important: our numbers are coming down modestly; the market is pricing something much more severe.”
Elsewhere, RBC Dominion Securities’ Paul Treiber lowered Vitalhub to “sector perform” from “outperform” with an $8 target, down from $11.
“VitalHub has a solid track record of compounding capital through acquisitions. However, with organic growth potentially continuing to slow in the near term, the ‘law of large numbers’ as an increasing headwind, and valuation likely to remain towards the low end of VitalHub’s historical range, we are downgrading the shares,” said Mr. Treiber.
Analysts making target revisions include:
* National Bank’s Doug Taylor to $10 from $12 with an “outperform” rating.
“U.K. revenue declined 12 per cent year-over-year amid continued disruption from the Palantir-powered FDP. Press headlines suggest uncertainty in the future of Palantir in the region as we approach break clause timing (February) with potential for renegotiation, extension (potentially two years), or another outcome. SHREWD represents 7-8 per cent of ARR (suggesting almost $10-million). Not all is considered at risk, but there is pressure as NHS customers suspend or defer contracts while awaiting certainty on the FDP program. This issue and associated headline risk remain a key impediment to attracting shareholder interest in light of VitalHub’s inexpensive valuation,” said Mr. Taylor.
In response to recent unit price outperformance, Desjardins Securities analyst Lorne Kalmar downgraded Automotive Properties Real Estate Investment Trust (APR.UN-T) to a “hold” rating from “buy” previously.
“Since September 30, APR has delivered a total return of 12 per cent vs a flat return for the S&P/TSX Capped REIT Index,” said Mr. Kalmar in a client note titled Put it in neutral.
“APR’s business has proven its resilience through several cycles, and we maintain that acquisitions are a key catalyst for outperformance. However, considering the REIT’s current leverage levels, we see limited acquisition upside vs our forecast absent an equity raise. With just a 13-per-cent total return to our $13.75 target price, we are moving our recommendation.”
After the bell on Thursday, the Toronto-based REIT reported funds from operations per unit of 26.6 cents, up 4 per cent year-over-year and in line with the analyst’s 26.5-cent estimate. Same-property cash net operating income grew 2.3 per cent year-over-year and is now up 2.2 per cent year-to-date.
“While the business has proven its stability through the pandemic and now tariffs, we see limited upside to our forecast at this time. We have long viewed the REIT’s acquisition program as a key catalyst for outperformance, and while we think there is still a large opportunity set, with D/ GBV at 47.1 per cent, leverage is running near the high end of management’s comfort zone (low 50 per cent),” he said.
“Our model currently incorporates $100-million of speculative acquisitions in both 2027 and 2028, with D/GBV forecast to reach 52 per cent by 4Q28. This suggests that in order for the REIT to exceed our acquisition forecast, it will likely need to issue equity. Higher rates could also inhibit acquisition activity by slowing dealership M&A (eg 2022, 2023, 2024), and fixed-rate debt represents just 76 per cent of total debt, giving it meaningful exposure on the interest rate front. On valuation, APR trades at 11.6 times FTM FFO [forward 12-month funds from operations] vs the LTA [long-term average] of 11.2 times, while the 6-per-cent NAV discount is in line with the historical average.”
Mr. Kalmar’s target fell by 25 cents to $13.75. The average is $13.33.
Elsewhere, National Bank’s Giuliano Thornhill increased his target to $13 from $12.50, keeping a “sector perform” rating.
“As expected, APR recycled its Vaughan Q3 disposition proceeds into higher-yielding assets. The Tesla acquired property will be overall accretive assuming mid-6-per-cent cap rate and 5-per-cent financing costs at approximately 50-per-cent leverage. Overall, tone on the conference call with respect to the M&A outlook is positive despite the higher-for-longer environment, and $50–$75-million of remaining acquisition capacity was outlined thanks to a building unencumbered asset pool ($166-million across 12 assets and growing). We continue to expect APR to make further inroads into the U.S. market where transaction activity tends to be higher than its Canadian home market, with recent M&A also to benefit from favourable leasing dynamics,” said Mr. Thornhill.
National Bank’s Cameron Doerksen is expecting “strong” growth to continue in 2027 for Exchange Income Corp. (EIF-T) following a third-quarter beat.
The Winnipeg-based company reported revenue of $1.057-billion, a gain of 10.2 per cent year-over-year and above the analyst’s $1.042-billion estimate driven by gains in its Manufacturing segment. Adjusted diluted earnings per share of $1.78 topped the $1.59 estimate of both Mr. Doerksen and the Street.
“Management reiterated its 2026 adjusted EBITDA guidance of $890-$920 million, but now expects to be at or above the high end of this range,” he said. “Guidance for 2027 was also introduced with a range of $1.00-$1.06 billion which compares to our prior forecast of $984 million and the current consensus of just over $1.0 billion. The guidance does not assume any new large-scale contract wins or unannounced M&A with key underlying organic drivers coming from the Regional One aircraft parts and leasing business and the Environmental Access Solutions segment.”
Mr. Doerksen now sees Exchange Income’s balance sheet “well positioned” for further growth.
“With $2.2 -billion in available liquidity and comfortable leverage at 2.64 times at quarter-end, EIC’s balance sheet is also positioned for additional M&A and/or organic capital investments,” he said. “On M&A, management is more focused on potential deals in its core verticals including tuck-ins that support existing businesses as we have seen with the recent TerraPro and Cartel acquisitions.”
Keeping an “outperform” rating, he raised his target to $150 from $145. The average is $149.
“Our positive view is based on the following: (1) We forecast 2027 EBITDA growth of 10 [er cent with positive trends across most of the company’s business lines set to continue into 2028; (2) As the largest aviation provider into Canada’s North and other remote areas, EIC is ideally positioned to see growth from Canada’s investment in defence and other infrastructure in the North over a multi-year period. We also see EIC benefiting from higher defence spending, not just in Canada, but also globally as the company’s aerial surveillance business could see new contract awards in the coming quarters; (3) The outlook for revenue growth in the company’s Manufacturing businesses is improving, especially for environmental matting in both the U.S. and Canada; (4) EIC’s balance sheet is positioned for additional M&A and/or organic capital investments,” said Mr. Doerksen.
Elsewhere, others making target revisions:
* Desjardins’ Gary Ho to $150 from $145with a “buy” rating.
“EIC delivered a record 3Q, with adjusted EBITDA well ahead of us and consensus on a favourable leasing mix at R1 and strong matting demand. 2026 guidance was raised for a fourth time, and inaugural 2027 guidance of $1.0–1.06-billion excludes new contract wins and M&A, leaving room for upside with leverage at a 15-year low. Our 2027 estimated EBITDA now sits at the mid-point of guidance,” said Mr. Ho.
*TD’s Tim James to $159 from from $153 with a “buy” rating.
“Q3 adj EBITDA beat, 2026 adj EBITDA guide and introduced 2027 EBITDA guide (up 12 per cent year-over-year at mid-point) highlight business strength, opportunities, and the resiliency of the business portfolio and M&A model. We believe Exchanges track record for strong adj. EBITDA/adj. EPS growth, our forecast for continued growth, thematic appeal, and limited downside risk supports our 11 times target EBITDA multiple,” said Mr. James.
* Scotia’s Konark Gupta to $157 from $150
* CIBC’s Krista Friesen to $157 from $151.
* Paradigm’s Razi Hasan to $160 from $155
In other analyst actions:
* In a client note reviewing its quarterly earnings titled Resilience in a turbulent environment, National Bank’s Zachary Evershed reduced his AGT Food and Ingredients Inc. (AGTF-T) target to $26 from $28.50, maintaining an “outperform” rating. The average on the Street is $25.
“North American harvest disruptions likely deferred $2.5-3.0 million of Adj. EBITDA, with catch up underway across Q4/26 and Q1/27. Lower commodity prices continue to pressure sales heading into Q4, however, and though private importers and returning customers are supporting VAP [value-added processing] demand, traditional food security activity remains subdued,” said Mr. Evershed.
* RBC’s Sabahat Khan raised his AutoCanada Inc. (ACQ-T) target to $27 from $24 with a “sector perform” rating, while Acumen Capital’s Trevor Reynolds increased his target to $30 from $27 with a “speculative buy” rating. The average is $25.
“ACQ reported Q3 Revenue below RBCe/consensus, while Adj. EBITDA was in line with RBC estimates and modestly ahead of consensus. Used Vehicle GPUs improved as the company continued to work through aged inventory, although New Vehicle margins remain under pressure. We expect investor focus to remain on the pace of improvement in dealership margins, as well as the outcome of the collision strategic review, while further deleveraging should support balance sheet flexibility,” said Mr. Khan.
* Following the announcement of the sale of its UK wealth business and an agreement to be taken private by Chairman and CEO Dan Daviau, TD Cowen’s Graham Ryding raised his Canaccord Genuity Group Inc. (CF-T) target to $19 from $18 with a “buy” rating. The average is $17.83.
“The UK Wealth deal looks attractive. The take private offer of $15.27/share looks light relative to our view of valuation ($19 target price, up from $18 previously). Canaccord also released FQ2/27 results (adjusted EPS beat us and consensus),” said Mr. Ryding.
* Scotia’s Jonathan Goldman increased his CES Energy Solutions Corp. (CEU-T) target to $24 from $22.50 with a “sector outperform” rating. The average is $23.36.
“CEU shares are up 18 per cent since reporting 2Q results in August, but we think it’s still early days for the stock,” said Mr. Goldman. “On the call, management said base case for 2027 is 10-per-cent top-line growth in a stable market with continued macro tailwinds representing upside. That underscores how the growth opportunity is supported by: 1) secular trend of higher service intensity; and 2) continued share gains/new market entry. Following the large tender win in U.S. production chemicals last year, the company continues to gain traction in Canadian heavy oil and is making slow, methodical progress in the Gulf of Mexico. Management quantified incremental revenue opportunity at $1-billion over a multi-year horizon. With 3Q results, the company also revised its adjusted EBITDA (i.e., EBITDAC) margin range upwards to 16-17 per cent (from 15.5-16.5 per cent). Putting it altogether, the math implies potential earnings power is 30 per cent higher than our 2027 estimate.”
* Seeing a “buying opportunity off tariff kerfuffle,” National Bank’s Nathan Po increased his target for Mattr Corp. (MATR-T) to $25 from $22 with an “outperform” rating. The average is $24.50.
“We believe last Friday’s 16-per-cent decline is overdone and consider this an opportunity for investors looking past the temporary curtailment in growth. Currently trading at 5.9 times 2028 estimated EV/EBITDA, we believe the market is giving little credit to management’s execution and MATR’s exposure to mining, utilities, nuclear and data centre end markets,” said Mr. Po.
* Ahead of its fourth-quarter earnings release on Wednesday, Desjardins Securities’ Chris Li raised his target for Metro Inc. (MRU-T) to $105 from $97 with a “buy” rating. The average is $102.25.
“The recent flight to safety has benefited the grocers, with MRU up 11 per cent since reporting 3Q results. Sentiment has also likely improved following the resolution of its six-month strike. While 4Q will reflect the strike impact and 1Q FY27 will also see some lingering effects, we believe investors view it as transitory. Longer-term, we believe the company has the levers in place to generate EPS growth in line with its 8–10-per-cent growth framework. Consistent execution could continue to drive share price appreciation,” said Mr. Li.
* Following a tour of its 90-per-cent-owned Koné mine in Côte d’Ivoire, National Bank’s Mohamed Sidibé raised his Montage Gold Corp. (MAU-T) target by $1 to $25 with an “outperform” rating. The average is $23.43.
“Near-term unit costs should be lower than we modelled, and we are more conservative beyond that. We got limited colour on operating costs. Oxide processing is less energy-intensive, so we expect lower costs in Q4/26–Q2/27. We now assume higher processing costs, haulage, and higher strip for some satellites, offset by resequenced satellites, higher grades, and more direct feed to the plant.,” said Mr. Sidibé.
* Desjardins Securities’ Brent Stadler increased his Northland Power Inc. (NPI-T) target to $23 from $22 with a “hold” rating, while TD Cowen’s Sean Steuart raised his target to $28 from $25 with a “buy” rating. The average is $25.90.
“In our view, Friday’s positive 6-per-cent share price reaction seems appropriate. Q3/26 results met tempered results; more importantly, NPI articulated incremental mid-stage development opportunities (877 MW) and provided useful context regarding return parameters for these projects. We do not include prospective projects in our valuation before FID, but NPI is on better footing after a tumultuous year,” said Mr. Steuart.
* National Bank’s Matt Kornack bumped his Northview Residential REIT (NRR.UN-T) target to $15.50 from $15 with a “sector perform” rating. The average is $16.30.
“After experiencing margin pressures during the first half of the year, Q3 saw a trend reversal, particularly on R&M [repair and maintenance] expense, where the variance to us largely drove the earnings beat in the quarter. SP [same-property] revenue growth was modest, with solid AMR [average monthly rent] improvement (up 3.6 per cent) being neutralized in part by lower occupancy (down 70 basis points). Here a change in management in the Ontario portfolio was partially to blame with Central Canada seeing a 410 basis points decline in SP occupancy. Rent and vacancy improvements were seen in the REIT’s two strongest regions (the Atlantic and North), while the Western portfolio saw higher rents but lower occupancy. We continue to think the portfolio is relatively well positioned to benefit from resource and defence investment ramp-up across the country,” said Mr. Kornack.
* Mr. Kornack also raised his PRO REIT (PRV.UN-T) target to $7.75, exceeding the $7.67 average, from $7.50 with a “sector perform” rating.
“Q3 results were good for PRO as it saw the benefits of conversion of committed leasing into in-place occupancy combined with strong leasing spreads during and subsequent to the quarter. On both metrics these KPIs exceeded our forecast resulting in a higher organic growth figure and cash/accounting NOI. On earnings, elevated G&A and interest expense neutralized some of the top-line outperformance but nonetheless our NAV moved higher as a result. Management noted an expectation for continued positive performance although occupancy will be choppy owing to tenant departures and leasing on currently vacant space with leasing spreads likely to be elevated through 2029,” said Mr. Kornack.